Alpha Teknova, Inc. — Earnings Quality Grade F
TKNO · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 42 days, change -0 days YoY
AR growth 7.1% vs revenue growth 7.4%
Revenue 7.4%, CFFO 30.2%. Cash follows revenue
Expense Quality
Inventory 3.7% vs COGS -11.3%. Normal
CapEx growth 2.0% vs revenue 7.4%. Normal
SG&A/Gross Profit = 201.4%, exceeds 70%
Gross margin swung +14.0pp (19.2% → 33.2%)
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
Small-cap context: Small-cap CFFO/NI often diverges from working-capital swings, not necessarily manipulation.
FCF is negative ($-0.0B)
Accruals ratio = -8.3%. Low accruals
Cash $0.0B covers 75% of debt $0.0B
Balance Sheet Health
Goodwill+Intangibles $0.0B = 17% of equity. Manageable
Interest coverage = -23.9x (<2x). Financial stress
Other assets -7.0% vs revenue 7.4%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
Goodwill+Intangibles change -9% YoY. Normal
Manipulation Score
M-Score = -3.04 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor TKNO continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25